MESOBLAST LTD (MESO) Form 10-K Annual Reports
MESOBLAST LTD (MESO) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MESO
CIK: 1345099
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 06/30
State: C3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers
Auditor SinceSince 6/30/2017 12:00:00 AM
Lead Engagement PartnerJonathan Roberts
Audit LocationMelbourne, Australia
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-16 | 2026-10-16 | 6-K | 0001345099-26-000091 | View SEC Doc Filr Page |
| 6-K | 2026-10-15 | 2026-10-14 | 6-K | 0001345099-26-000089 | View SEC Doc Filr Page |
| 6-K | 2026-10-13 | 2026-10-13 | 6-K | 0001345099-26-000087 | View SEC Doc Filr Page |
| 6-K | 2026-09-24 | 2026-09-24 | 6-K | 0001345099-26-000085 | View SEC Doc Filr Page |
| 6-K | 2026-08-27 | 2026-08-27 | 6-K | 0001345099-26-000083 | View SEC Doc Filr Page |
| 20-F | 2026-08-27 | 2026-06-30 | 20-F | 0001345099-26-000081 | View SEC Doc Filr Page |
| 6-K | 2026-08-25 | 2026-08-25 | 6-K | 0001345099-26-000078 | View SEC Doc Filr Page |
| 6-K | 2026-08-24 | 2026-08-24 | 6-K | 0001345099-26-000076 | View SEC Doc Filr Page |
| 6-K | 2026-08-18 | 2026-08-17 | 6-K | 0001345099-26-000074 | View SEC Doc Filr Page |
| 6-K | 2026-07-30 | 2026-07-30 | 6-K | 0001345099-26-000072 | View SEC Doc Filr Page |
| 6-K | 2026-07-21 | 2026-07-21 | 6-K | 0001345099-26-000070 | View SEC Doc Filr Page |
| 6-K | 2026-07-15 | 2026-07-14 | 6-K | 0001345099-26-000068 | View SEC Doc Filr Page |
| 6-K | 2026-07-14 | 2026-07-14 | 6-K | 0001345099-26-000066 | View SEC Doc Filr Page |
| 6-K | 2026-07-10 | 2026-07-10 | 6-K | 0001345099-26-000064 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-07 | 4 Filing | 0001213900-26-076893 | View SEC Doc Filr Page |
| 6-K | 2026-07-01 | 2026-07-01 | 6-K | 0001345099-26-000062 | View SEC Doc Filr Page |
| 6-K | 2026-06-25 | 2026-06-25 | 6-K | 0001345099-26-000060 | View SEC Doc Filr Page |
| 6-K | 2026-06-10 | 2026-06-10 | 6-K | 0001345099-26-000058 | View SEC Doc Filr Page |
| 6-K | 2026-04-30 | 2026-04-30 | 6-K | 0001345099-26-000055 | View SEC Doc Filr Page |
| 3 | 2026-04-29 | 2026-03-18 | 3 Filing | 0001213900-26-048797 | View SEC Doc Filr Page |
| 6-K | 2026-04-29 | 2026-04-29 | 6-K | 0001345099-26-000051 | View SEC Doc Filr Page |
| 6-K | 2026-04-17 | 2026-04-17 | 6-K | 0001345099-26-000049 | View SEC Doc Filr Page |
| 6-K | 2026-04-15 | 2026-04-15 | 6-K | 0001345099-26-000047 | View SEC Doc Filr Page |
| 4 | 2026-04-13 | 2026-04-09 | FORM 4 | 0001999371-26-008132 | View SEC Doc Filr Page |
| 4 | 2026-04-10 | 2026-04-09 | FORM 4 | 0001999371-26-008124 | View SEC Doc Filr Page |